Cardiac surgery involves the heart and the great vessels connected to the heart. It is often performed to treat ischemic heart disease, congenital heart disease, valvular heart disease as well as heart transplantation. The first cardiac surgeries were performed in the 19th century on the pericardium, the sac that surrounds the heart. The first surgery on the heart itself was performed in 1895 in Oslo, Norway. Surgeon Axel Cappelen ligated the bleeding coronary artery of a 24-year-old patient who had been stabbed under his left arm. The patient survived for over two days but later passed away due to infection from the procedure. Approximately one year afterwards, a successful operation was performed in Germany on another patient with a stabbing injury. There are many risks associated with performing cardiac surgery. Patients often suffer from neurological damage and strokes after procedures. Neurological damage is more common when an ONCAB procedure is performed; many patients suffer from post-perfusion syndrome, which is a combination of neurological conditions that can affect patients after surgery. These symptoms can be temporary or permanent.
'
TABLE OF CONTENTS I
LIST OF FIGURES XI
LIST OF CHARTS XIX
EXECUTIVE SUMMARY 1
U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 11
PROCEDURE NUMBERS 12
PROCEDURE CODES INVESTIGATED 16
MARKETS INCLUDED 17
KEY REPORT UPDATES 19
VERSION HISTORY 20
RESEARCH METHODOLOGY 21
Step 1: Project Initiation & Team Selection 21
Step 2: Prepare Data Systems and Perform Secondary Research 24
Step 3: Preparation for Interviews & Questionnaire Design 26
Step 4: Performing Primary Research 27
Step 5: Research Analysis: Establishing Baseline Estimates 29
Step 6: Market Forecasts and Analysis 30
Step 7: Identify Strategic Opportunities 32
Step 8: Final Review and Market Release 33
Step 9: Customer Feedback and Market Monitoring 34
DISEASE OVERVIEW 35
2.1 BASIC ANATOMY 35
2.1.11 Coronary Artery Disease 37
2.1.12 Myocardial Infarction 37
2.1.13 Angina Pectoris 38
2.1.14 Heart Valve Disease 39
2.1.15 Congestive Heart Failure 39
U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 41
3.1 INTRODUCTION 41
3.2 MARKET OVERVIEW 43
3.3 TREND ANALYSIS BY SEGMENT 49
3.4 DRIVERS AND LIMITERS 54
3.4.1 Market Drivers 54
3.4.2 Market Limiters 55
3.5 COMPETITIVE MARKET SHARE ANALYSIS 57
3.6 COMPANY PROFILES 63
3.6.1 Edwards Life Sciences 63
3.6.2 Medtronic 63
3.6.3 St. Jude Medical 66
3.6.4 MAQUET 67
3.6.5 Abiomed 68
3.6.6 HeartWare Inc 69
3.7 COMPANY SWOT ANALYSIS 70
3.7.1 Edwards Life Sciences 70
3.7.2 Medtronic 71
3.7.3 St. Jude Medical 72
3.7.4 MAQUET 73
3.7.5 Abiomed 74
3.7.6 HeartWare Inc. 75
ABBREVIATIONS 76
APPENDIX: COMPANY PRESS RELEASES 79
Chart 1 1: Cardiac Surgery and Heart Valve Devices Market by Segment, U.S., 2014 – 2024 3
Chart 1 2: Cardiac Surgery and Heart Valve Devices Market Overview, U.S., 2017 & 2024 3
Chart 4 1: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 – 2024 47
Chart 4 2: Cardiac Surgery and Heart Valve Device Market Breakdown, U.S., 2017 48
Chart 4 3: Cardiac Surgery and Heart Valve Device Market Breakdown, U.S., 2024 48
Chart 4 4: Growth Rates by Segment, Cardiac Surgery and Heart Valve Device Market, U.S., 2014 – 2024 53
Chart 4 5: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 62
Figure 1 1: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (1 of 4) 4
Figure 1 2: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (2 of 4) 5
Figure 1 3: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (3 of 4) 5
Figure 1 4: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (4 of 4) 5
Figure 1 5: Companies Researched in this Report, U.S., 2017 6
Figure 1 6: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (1 of 4) 7
Figure 1 7: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (2 of 4) 8
Figure 1 8: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (3 of 4) 9
Figure 1 9: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (4 of 4) 10
Figure 1 10: Recent Events in the Cardiac Surgery and Heart Valve Devices Market, U.S., 2015 – 2017 11
Figure 1 11: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (1 of 4) 12
Figure 1 12: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (2 of 4) 13
Figure 1 13: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (3 of 4) 14
Figure 1 14: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (4 of 4) 15
Figure 1 15: Procedure Codes Investigated, U.S., 2017 16
Figure 1 16: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (1 of 2) 17
Figure 1 17: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (2 of 2) 18
Figure 1 18: Key Report Updates (1 of 2) 19
Figure 1 19: Key Report Updates (2 of 2) 20
Figure 1 20: Version History 20
Figure 4 1: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 – 2024 (US$M) (1 of 3) 44
Figure 4 2: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 – 2024 (US$M) (2 of 3) 45
Figure 4 3: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 – 2024 (US$M) (3 of 3) 46
Figure 4 4: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2014 – 2024 (1 of 3) 50
Figure 4 5: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2014 – 2024 (2 of 3) 51
Figure 4 6: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2014 – 2024 (3 of 3) 52
Figure 4 7: Drivers and Limiters, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 56
Figure 4 8: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 (1 of 3) 59
Figure 4 9: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 (2 of 3) 60
Figure 4 10: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 (3 of 3) 61
Figure 4 11: SWOT Analysis, Edwards Life Sciences, 2017 70
Figure 4 12: SWOT Analysis, Medtronic, 2018 71
Figure 4 13: SWOT Analysis, St. Jude Medical, 2018 72
Figure 4 14: SWOT Analysis, MAQUET, 2018 73
Figure 4 15: SWOT Analysis, Abiomed, 2018 74
Figure 4 16: SWOT Analysis, HeartWare Inc, 2018 75
Figure 25 1: Press Release Summary 79
Edwards Lifesciences
St. Jude Medical
Medtronic
Maquet
Abiomed
HeartWare Inc.
Sorin Group
Terumo
Abbott Laboratories
Teleflex Medical
Cardiac Assist
AtriCure
W.L. Gore
SynCardia
Boston Scientific
Cryolife
Others include: Berlin Heart, Cardica, Chase Medical, Genesee Biomedical, Karl Storz, LifeNet Health, Microline Surgical, Novadaq, On-X, Saphena Medical, SentreHeart, Vitalitec, etc.
